Work

42268 Real-World Utilization of Adalimumab Biosimilar (ABP 501) in Patients with Psoriasis in Europe

Year: 2023

Type: article

Study design: Observational Study

Source: Journal of the American Academy of Dermatology

DOI: 10.1016/j.jaad.2023.07.866

Authors: Ran Jin, Eleanor Wrest, James Haughton, James Piercy, Rachel Meadows, Waldemar Radziszewski

Institution: Amgen (United States)

Language: English

Topic: Psoriasis: Treatment and Pathogenesis

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4387026403

FWCI:

Cites:

Cited by:

Related to: 10